Introduction and Objective: There is a decades old perception that women of African descent prefer large body sizes. Even though body size preference is a major determinant of health behavior, the 21st century view of body size preference in African immigrant (Afr-Im) and African American (AA) women is unknown. Our goal was to assess and […]
Read MoreMonth: June 2026
2250-P: Incidence and Risk Factors of Pancreatogenic Diabetes: A Systematic Review and Meta-Analysis
Introduction and Objective: Pancreatogenic diabetes (T3cDM) results from pancreatic exocrine dysfunction leading to endocrine insufficiency. Although linked to acute/chronic pancreatitis (AP/CP) and pancreatic cancer (PC), the incidence and predictors of diabetes after these conditions require clarification. This study determines the pooled incidence of new-onset diabetes following AP, CP, and PC and identifies disease-specific risk factors.Methods: […]
Read More2927-LB: Generative AI Improves Previsit Efficiency in Virtual Nationwide Cardiometabolic Health Practice
Introduction and Objective: Multidisciplinary obesity and diabetes care requires coordination across providers and multiple data sources, often involving extensive time on documentation and chart review. We evaluated whether implementation of a real-time, AI-generated structured patient summary could improve clinician efficiency and satisfaction.Methods: In a large nationwide virtual obesity clinic, we conducted a pre-post evaluation of […]
Read More1140-OR: Altered Muscle Content and Secretion of microRNAs Impacts Muscle and Fat Metabolism in Type 2 Diabetes
Introduction and Objective: miRNAs are emerging as significant metabolic regulators and are altered at both the cellular and secreted levels in diseases, including type 2 diabetes (T2D). However, to what extent alterations in miRNA content and secretion are cell-intrinsic, and how they play a role in disease pathogenesis, remains unclear.Methods: In the present study, we […]
Read More1023-OR: Divergent Exocrine Pancreatic Trajectories in Children Progressing to Stage 1 vs. Stage 3 Type 1 Diabetes
Introduction and Objective: Exocrine pancreas dysfunction is evident in presymptomatic type 1 diabetes (T1D), yet its natural history remains unclear. We evaluated whether longitudinal decline in fecal elastase (FE-1) tracks more closely with islet autoimmunity or progression to dysglycemia and assessed its predictive utility.Methods: In a nested case-control study within The Environmental Determinants of Diabetes […]
Read More1092-OR: A Kinase-Mediated Signaling and Glucose-Uptake Defect in Human Insulin Resistance
Introduction and Objective: Insulin resistance is a major risk factor in the development of type 2 diabetes (T2D) and metabolic syndrome. Although ~25% of people within the general non-diabetic population are insulin resistant, the primary underlying cause of insulin resistance remains elusive.Methods: In this study, we have used induced pluripotent stem cells (iPSC) derived from […]
Read More1757-P: Development of an Ultra-Stable Insulin That Can Withstand Heat
Introduction and Objective: We are developing an ultra-stable insulin analog designed to address the intrinsic physical instability of current insulin formulations. Using advanced protein structural insights and protein engineering approaches originating from UT Southwestern, we focused on optimizing insulin analogs to reduce fibrillation and aggregation while improving resistance to thermal and mechanical stress across a […]
Read More2031-P: Correlation of Minoritized Ethnicity Representation between Patients and Staff of Diabetes Centers Involved in the T1D Exchange Quality Improvement Collaborative
Introduction and Objective: T1D Exchange Quality Improvement Collaborative (T1DX-QI) administered a survey to evaluate characteristics of patient and clinic workforce and QI initiatives underway to support people with type 1 and type 2 diabetes (PwT1D and PwT2D).Methods: The T1DX-QI survey was administered August-October 2025 to collect 2024 data. Descriptive analyses summarized racial/ethnic diversity of clinical […]
Read More2592-P: Impact of Once-Weekly Injectable Semaglutide vs. Placebo on Fatty Liver Index Scores in People with Overweight/Obesity: A Post Hoc Analysis (STEP1)
Introduction and Objective: Fatty liver index (FLI) is a diagnostic tool in metabolic dysfunction-associated steatotic liver disease, an end-organ complication in overweight/obesity. This post hoc analysis assessed the impact of injectable semaglutide (sema) 2.4 mg versus placebo on FLI scores in STEP 1.Methods: People with information needed to calculate FLI scores (BMI, waist circumference, triglycerides […]
Read More2715-LB: Short Lipidated Peptide (SLiP) Targeting Nav1.8 for Treating Neuropathic Pain
Introduction and Objective: Diabetic peripheral neuropathy remains a major therapeutic challenge, with over 50% of patients responding inadequately to existing non-opioid therapies (gabapentinoids, SNRIs, TCAs). Dorsal root ganglion (DRG) neurons serve as the primary sites for injury-induced plasticity underlying painful peripheral pathophysiologies. Voltage-gated sodium channels (VGSC), specifically Nav1.8, are highly expressed in DRGs and are […]
Read More